Game-changing gene therapy to treat blood cancer approved by the FDA

The Food and Drug Administration on Wednesday approved a promising new treatment for a particularly deadly form of cancer, bringing hope to desperate patients while rekindling a global conversation about the escalating cost of new therapies.

The treatment, made by Gilead Sciences, is made by extracting patients’ white blood cells and re-engineering them to home in on tumors. Called a CAR-T, the one-time treatment has shown unprecedented results for patients with dire diagnoses.

SEE ALSO: Nobel Prize goes to researchers who uncovered the inner workings of the biological clock

Gilead’s treatment, to be sold as Yescarta, is the second CAR-T to win FDA approval but the first cleared for use in adults. A similar therapy from Novartis, approved in August, is used for children with an aggressive form of blood cancer. Read more...

More about Science, Health, Cancer, Fda, and Cancer Treatment

COntributer : Mashable http://ift.tt/2gn86RY

Exhibit rare genuine handcrafted multi-ethnic products of the people in Island of Borneo!